http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2701531-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_821a6739093a95150d2980c6da6a2d3b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-242 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-2408 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-2458 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5728 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 2014-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_507e55e939c8a1b848ac20e210452ebf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa7e0c47c521d999b6d474557908c0b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69fe3860ae749d6119698b260cc8c074 |
| publicationDate | 2019-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2701531-T3 |
| titleOfInvention | Pantothenate derivatives for the treatment of neurological disorders |
| abstract | Compound having the formula: ** (See formula) ** or a pharmaceutically acceptable salt thereof, wherein R is an amino acid side chain; each occurrence of X is independently halogen, alkyl, alkenyl, halogenated alkyl, -CN, -NO2, -C (O) 2R1, -C (O) R1 or -OR2; n is 1, 2, 3, 4 or 5; each occurrence of R1 is independently C1-6 alkyl; each occurrence of R2 is independently C1-6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, aryl or polyethylene glycol (PEG), each of which is optionally substituted with one or more halogens; R 'is C1-C20 alkyl, C2-C20 alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, cycloalkenylalkyl, aryl, arylalkyl, heterocyclyl, heteroaryl, heterocyclylalkyl or heteroarylalkyl, each of which is optionally substituted with one or more; and R "is substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C2-C20 alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted cycloalkylalkyl, substituted or unsubstituted cycloalkenyl alkyl substituted, substituted or unsubstituted aryl, substituted or unsubstituted arylalkyl, substituted or unsubstituted heterocyclyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocyclyl alkyl, substituted or unsubstituted heteroarylalkyl or PEG, each of which is optionally substituted with one or more halogens. |
| priorityDate | 2013-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 433.